机译:Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
机译:Cancer stem-like cells evade CD8(+)CD103(+) tumor-resident memory T (T-RM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model
机译:Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up
机译:Cancer stem-like cells evade CD8(+)CD103(+) tumor-resident memory T (T-RM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model
机译:Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
机译:Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy (vol 9, e003439, 2021)
机译:Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
机译:Albumin and interferon-beta fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+T cell-mediated antitumor immunity
机译:Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
机译:Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
机译:Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer (vol 9, e003973, 2021)